Výsledky vyhledávání - "M. N. Piccinni"

A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy

Autor: Ivano Franzetti, Elena Fogari, Arrigo Fg Cicero, Angela D'Angelo, Anna Carbone, Giuseppe Derosa, Pamela Maffioli, Fabrizio Querci, M. N. Piccinni

Publikováno v: Diabetic Medicine. 30:846-854

Aims To evaluate which triple oral therapy between metformin + pioglitazone + sitagliptin and metformin + pioglitazone + glibenclamide can be more useful in improving glycaemic control and should be preferred in clinical practice. Methods During the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7702252286bf22a2b458b455cabb1a55
https://doi.org/10.1111/dme.12158

Zobrazit plný text záznamu

Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes

Autor: M. N. Piccinni, Pamela Maffioli, Anna Carbone, Elena Fogari, Leonardina Ciccarelli, Fabrizio Querci, Giuseppe Derosa, Ig Franzetti

Publikováno v: Diabetic Medicine. 29:1515-1523

Diabet. Med. 29, 1515–1523 (2012) Abstract Aim To quantify how much exenatide added to metformin improves β-cell function, and to evaluate the impact on glycaemic control, insulin resistance and inflammation compared with metformin alone. Methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a90e2b202ad1f62db4f749e38f87f97c
https://doi.org/10.1111/j.1464-5491.2012.03699.x

Zobrazit plný text záznamu

Effects of One Year Treatment of Vildagliptin Added to Pioglitazone or Glimepiride in Poorly Controlled Type 2 Diabetic Patients

Autor: Ivano Franzetti, G Gadaleta, Ilaria Ferrari, P. D. Ragonesi, Giuseppe Derosa, M. N. Piccinni, Angela D'Angelo, Roberto Mereu, Fabrizio Querci, S. A. T. Salvadeo, Leonardina Ciccarelli, Pamela Maffioli

Publikováno v: Hormone and Metabolic Research. 42:663-669

The aim of the study was to compare the effects of vildagliptin added to pioglitazone or glimepiride on metabolic and insulin resistance related-indices in poorly controlled type 2 diabetic patients (T2DM). 168 patients with T2DM were randomized to t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bae8cc22d17605feab7e99649b4f24f6
https://doi.org/10.1055/s-0030-1255036

Zobrazit plný text záznamu

Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome

Autor: M. N. Piccinni, Ilaria Ferrari, S. Paniga, Angela D'Angelo, Giuseppe Derosa, Leonardina Ciccarelli, S. A. T. Salvadeo, Fabio Pricolo, Lorenza Montagna, Alessia Gravina, P. D. Ragonesi, Arrigo F G Cicero

Publikováno v: Journal of Clinical Pharmacy and Therapeutics. 31:375-383

Summary Background and objective: Metformin is considered the gold standard for type 2 diabetes treatment as monotherapy and in combination with sulphonylureas and insulin. The combination of metformin with thiazolidinediones is less well studied. Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af734d81def17a2c3447deb72239dcd4
https://doi.org/10.1111/j.1365-2710.2006.00756.x

Zobrazit plný text záznamu

Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients

Autor: Arrigo F G Cicero, Giuseppe Murdolo, Gianandrea Bertone, M. N. Piccinni, Leonardina Ciccarelli, Giuseppe Derosa, Roberto Fogari, Elena Fogari

Publikováno v: Diabetes, Obesity and Metabolism. 7:47-55

Aim: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibutramine treatment in obese hypertensive patients, with a specific attention to cardiovascular effects and to side effects because of this treatment. M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ebfd9b25790c2e00d6d17c3012cd635
https://doi.org/10.1111/j.1463-1326.2004.00372.x

Zobrazit plný text záznamu

Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes

Autor: G, Derosa, I G, Franzetti, F, Querci, A, Carbone, L, Ciccarelli, M N, Piccinni, E, Fogari, P, Maffioli

Publikováno v: Diabetic medicine : a journal of the British Diabetic Association. 29(12)

To quantify how much exenatide added to metformin improves β-cell function, and to evaluate the impact on glycaemic control, insulin resistance and inflammation compared with metformin alone.A total of 174 patients with Type 2 diabetes with poor gly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5b23173080857bac084703c2b757f441
https://pubmed.ncbi.nlm.nih.gov/22540883

Zobrazit plný text záznamu

Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients

Autor: G. Derosa, P. Maffioli, S. A. Salvadeo, I. Ferrari, P. D. Ragonesi, F. Querci, I. G. Franzetti, G. Gadaleta, L. Ciccarelli, M. N. Piccinni, A. D'Angelo, CICERO, ARRIGO FRANCESCO GIUSEPPE

The aim of the study was to compare the effects of the addition of sitagliptin or metformin to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients on body weight, glycemic control, beta-cell function, insulin resistance, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4094::1fb472b0f6632e1f97f698ef737cdfae
http://hdl.handle.net/11585/104731

Zobrazit plný text záznamu

Exenatide versus glibenclamide in patients with diabetes

Autor: G Gadaleta, M. N. Piccinni, Giuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, P. D. Ragonesi, Fabrizio Querci, S. A. T. Salvadeo, Ivano Franzetti, Arrigo F G Cicero, Leonardina Ciccarelli, Angela D'Angelo

BACKGROUND: Incretin-based therapies have provided additional options for the treatment of type 2 diabetes mellitus. The aim of our study was to evaluate the effects of exenatide compared to glibenclamide on body weight, glycemic control, beta-cell f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e80c1affc7f40279f230c22f848e0b38
http://hdl.handle.net/11585/104113

Zobrazit plný text záznamu

Matrix metalloproteinase-2 and -9 levels in obese patients

Autor: Ilaria Ferrari, Giuseppe Derosa, F. Ramondetti, Arrigo F G Cicero, M. N. Piccinni, Angela D'Angelo, Carmine Tinelli, S. A. T. Salvadeo, Alessia Gravina, Leonardina Ciccarelli, Pamela Maffioli

Publikováno v: Endothelium : journal of endothelial cell research. 15(4)

The data reported in literature revealed a novel function for matrix metalloproteinases ( MMPs) as modulators of adipogenesis. However, their expression profile and role in the cellular microenvironment during obesity-mediated adipose tissue developm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31b1be576f4de491ef87d6bc9c55f0d
https://pubmed.ncbi.nlm.nih.gov/18663625

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání